Spirepoint Private Client »

Vaneck Vectors Pharmaceutical etf shares owned by Spirepoint Private Client

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Spirepoint Private Client from 13F filings

Historical chart of Spirepoint Private Client investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Spirepoint Private Client consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Spirepoint Private Client

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.0M 12k 86.28
2024-09-30 $1.0M 11k 95.03
2024-06-30 $1.1M 12k 91.48
2024-03-31 $995k 11k 90.70

More positions owned by Spirepoint Private Client

United Parcel Service CL B (UPS)
Apple (AAPL)
Microsoft Corporation (MSFT)
Clean Harbors (CLH)
Broadcom (AVGO)
NVIDIA Corporation (NVDA)
Palantir Technologies Cl A (PLTR)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Procter & Gamble Company (PG)
Johnson & Johnson (JNJ)
Alps Etf Tr Alerian Mlp (AMLP)
Royal Caribbean Cruises (RCL)
Nextera Energy (NEE)
Select Sector Spdr Tr Technology (XLK)

View all positions for Spirepoint Private Client

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
J.Safra Asset Management
Mivtachim The Workers Social Insurance Fund
Miller Investment Management
Thrivent Financial for Lutherans
Adamsbrown Wealth Consultants
Two Sigma Investments
Prime Capital Investment Advisors
Bank of America Corporation
Morgan Stanley
Susquehanna International
Bnp Paribas Arbitrage, Snc
Independent Advisor Alliance

View all funds holding Vaneck Vectors Pharmaceutical etf